GlobeNewswire

Percona Announces Full Conference Schedule for Percona Live Open Source Database Conference Europe 2017

Dela

RALEIGH, N.C., Sept. 06, 2017 (GLOBE NEWSWIRE) -- Percona, the company that delivers enterprise-class MySQL®, MongoDB® and other open source database solutions and services, today unveiled the full conference schedule for Percona Live Open Source Database Conference Europe 2017, taking place September 25-27, 2017 at the Radisson Blu Royal Hotel in Dublin, Ireland. The Advanced Registration Discount rate expires on September 5, 2017. Sponsorship opportunities are still available.

The Percona Live Open Source Database Conference Europe, which was completely sold-out in 2016, is the premier event for individuals and businesses developing and using open source software.

The conference theme this year is "Championing Open Source Databases," with sessions on MySQL, MariaDB, MongoDB and other open source database technologies, including time series databases, PostgreSQL and RocksDB. The 2017 conference will feature a range of keynote addresses, in-depth discussions and hands-on tutorials for three formal tracks - Developer, Business/Case Studies and Operations.

The conference includes more than 100 keynotes, tutorials and breakout sessions. A sampling of each includes:

Keynote Addresses
Tuesday, September 26, 2017

  • Championing Open Source Databases - Peter Zaitsev (Percona)
  • PMM Demo - Michael Coburn (Percona)
  • MySQL as a Layered Service: How to Use ProxySQL to Control Traffic and Scale Out - Rene Cannao (ProxySQL)
  • Real Time DNS Analytics at Cloudflare with ClickHouse - Tom Arnfeld (Cloudflare)
  • Why Open Sourcing Our Database Tooling Was the Smart Decision - Shlomi Noach (GitHub)
  • MyRocks at Facebook and a Roadmap - Yoshinori Matsunobu (Facebook)
  • Prometheus for Monitoring Metrics - Brian Brazil (Prometheus/Robust Perception)

Wednesday, September 27, 2017

  • State of the Dolphin - Geir Høydalsvik (Oracle)
  • Q&A with the authors of "Database Reliability Engineering" - Laine Campbell (Fastly/OpsArtisan) and Charity Majors (Honeycomb)
  • Many Faces of Continuent Tungsten - MC Brown (Continuent)
  • Customer Keynote: Database Performance in High Traffic Environments - Pavel Genov (Pepper)

Tutorials
Monday, September 25, 2017

Breakout Sessions
Tuesday, September 26, 2017  

MySQL/MariaDB

MongoDB

Open Source Databases

Wednesday, September 27, 2017

MySQL/MariaDB

MongoDB

Open Source Databases

Sponsorships
Sponsor ship opportunities for the Percona Live Open Source Database Conference Europe 2017 are available and offer the opportunity to interact with DBAs, sysadmins, developers, CTOs, CEOs, business managers, technology evangelists, solution vendors, and entrepreneurs who typically attend the event. Current sponsors include:

Diamond Sponsor - Continuent
Gold Sponsors - Facebook, VividCortex
Exhibitor Sponsors - Altinity, Ispirer, PGDAY Russia '17, Rackspace, Severalnines, TimescaleDB
Contributor Sponsors - Webyog, Oracle MySQL
Media Sponsors - CMSWire, Datanami, InsideBigData, InsideHPC, ODBMS.org, Opensource.com, O'Reilly Media

Eero Teerikorpi, Founder & CEO, Continuent
"Continuent is very excited to once again be participating as a Diamond Sponsor in Percona Live Europe, the premier open source database conference," said Eero Teerikorpi, Founder and CEO, Continuent Ltd. "The event is an excellent meeting place for Europe's diverse open source database community who use Tungsten Clustering, our state-of-the-art MySQL clustering solution for multi-site, multi-master deployments, and Tungsten Replicator for real-time data loading into analytics."

Percona Live Conferences

What:    Percona Live Open Source Database Conference Europe 2017 
Where:   Radisson Blu Royal Hotel, 8 Golden Lane, Dublin, Ireland
When:     September 25-27, 2017        


About Percona

With more than 3,000 customers worldwide, Percona is the only company that delivers enterprise-class solutions for both MySQL®, MongoDB® and other open source databases across traditional and cloud-based platforms. The company provides SoftwareSupport,  Consulting, and Managed Services to large, well-known global brands such as Cisco Systems, Time Warner Cable, Alcatel-Lucent, Rent the Runway and the BBC, as well as smaller enterprises looking to maximize application performance while streamlining database efficiencies. Well established as thought leaders, Percona experts author content for the Percona Database Performance Blog and the Percona Live Open Source Database Conferencesdraw attendees and expert technical speakers from around the world. For more information, visit www.percona.com.

Percona®, XtraBackup®, TokuDB® and Fractal Tree® are registered trademarks of Percona LLC or its subsidiaries. All other registered and unregistered trademarks in this document are the sole property of their respective owners.

 

Company Information

Press Contact
Brigit Valencia
For Percona
(360) 597-4516
bdbvalencia@gmail.com



This announcement is distributed by Nasdaq Corporate Solutions on behalf of Nasdaq Corporate Solutions clients.
The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: Percona via Globenewswire

Om

GlobeNewswire



Följ GlobeNewswire

Abonnera på våra pressmeddelanden.

Senaste pressmeddelandena från GlobeNewswire

Karolinska Development's portfolio company Modus Therapeutics completes enrollment in Phase II study with sevuparin7.1.2019 12:00Pressmeddelande

STOCKHOLM, January 7, 2019. Karolinska Development's portfolio company Modus Therapeutics announces that the patient enrollment has been completed in the Phase II study with sevuparin in patients with sickle cell disease (SCD). The results from the study is expected in mid 2019. Modus Therapeutic's randomized, double blind study contains 140 SCD-patients with Acute Vaso Occlusive Crisis (VOC). It compares intravenously administered sevuparin with placebo. The primary endpoint of the study is the demonstration of a reduced time to resolution of patient's VOC. Clincal sites across Europe and the Middle East took part in the study that was conducted in conjunction with Modus Therapeutics' co development partner Ergomed. SCD has a high unmet medical need as there are currently no approved therapies for VOCs. It is an inherited blood disorder that affects between 90,000 to 100,000 patients in the U.S. and is characterized by severely painful VOCs that lead to organ damage due to a lack of o

Karolinska Development's portfolio company Modus Therapeutics completes enrollment in Phase II study with sevuparin7.1.2019 12:00Pressmeddelande

STOCKHOLM, January 7, 2019. Karolinska Development's portfolio company Modus Therapeutics announces that the patient enrollment has been completed in the Phase II study with sevuparin in patients with sickle cell disease (SCD). The results from the study is expected in mid 2019. Modus Therapeutic's randomized, double blind study contains 140 SCD-patients with Acute Vaso Occlusive Crisis (VOC). It compares intravenously administered sevuparin with placebo. The primary endpoint of the study is the demonstration of a reduced time to resolution of patient's VOC. Clincal sites across Europe and the Middle East took part in the study that was conducted in conjunction with Modus Therapeutics' co development partner Ergomed. SCD has a high unmet medical need as there are currently no approved therapies for VOCs. It is an inherited blood disorder that affects between 90,000 to 100,000 patients in the U.S. and is characterized by severely painful VOCs that lead to organ damage due to a lack of o

Stillfront Group rekryterar ansvarig för M&A19.12.2018 12:07Pressmeddelande

PRESSMEDDELANDE 19 december, 2018 Stillfront Group rekryterar ansvarig för M&A Stillfront Group, en marknadsledare inom 'free to play' online strategispel, annonserar idag att Marina Andersson har utsetts till ansvarig för M&A och kommer att ingå i koncernledningen. Marina har närmare tjugo års erfarenhet från investment banking och M&A. Hon har omfattande erfarenhet inom strategisk och finansiell rådgivning, affärsgenerering, projektledning inom förvärv och försäljningar av företag, finansiell analys, due diligence, samt företagsvärdering. Tidigare positioner inkluderar: Director, Deloitte's Corporate Finance Advisory team, Director, ICECAPITAL Securities, Associate Partner och Investment Manager, Deseven, samt M&A Analytiker på Carnegie. Marina har två magister-examen från Stockholms universitet och Russian Herzen State Pedagogical University. "Förvärv är en viktig del av Stillfronts affärsstrategi och vi är mycket glada att rekrytera Marina Andersson. Marinas breda erfarenhet och pr

Stillfront Group announces Head of M&A19.12.2018 12:07Pressmeddelande

PRESS RELEASE December 19, 2018 Stillfront Group announces Head of M&A Stillfront Group, a market leader in 'free to play' online strategy games, today announces that Marina Andersson has been appointed as Head of M&A and will be part of the Group's management team. Marina has close to 20 years track record of investment banking and M&A. She has extensive competence within strategic and financial advisory, deal generation, buy and sell side M&A project management, financial analysis, due diligence and company valuation. Former positions include: Director at Deloitte's Corporate Finance Advisory team, Director at ICECAPITAL Securities, Associate Partner and Investment Manager at Deseven, M&A Analyst at Carnegie. She holds two Master degrees from Stockholm University and Russian Herzen State Pedagogical University. "Acquisitions are a crucial part of Stillfront's business strategy and we are very pleased with the appointment of Marina Andersson. Marina's breadth of experience and profess

Oboya tecknar ett samarbetsavtal med Gaia avseende biomaterial13.12.2018 11:41Pressmeddelande

Oboya Horticulture Industries AB (publ) ("Oboya") har tecknat ett viktigt och långsiktigt samarbetsavtal avseende miljövänligt biomaterial med Gaia Biomaterials AB ("Gaia") i Helsingborg, Sverige. Avtalet innebär att Oboya använder Gaias biomaterial för tillverkning och utveckling av miljövänliga odlingsprodukter till odlingsindustrin. Oboya har under de senaste åren arbetat aktivt med innovation, miljö- och hållbarhetsfrågor och vårt mål är att främja miljö och hållbarhet inom odlingsindustrin genom att erbjuda miljövänliga odlingsprodukter till våra kunder. Oboya anser att användningen av biomaterial kommer att vara viktigt för framgång i omställningen till en fossilfri odlingsindustri världen över. Samarbetsavtalet innebär att Oboya använder Gaias biomaterial i sin produktion och att vi genom Gaias kompetens kan utveckla nya miljövänliga odlingsprodukter. Gaias biomaterial är biologiskt nedbrytbart, komposterbart samt ger upp till 80 % lägre koldioxidutsläpp vid förbränning jämfört

Oboya signs a cooperation agreement with Gaia regarding biomaterials13.12.2018 11:41Pressmeddelande

Oboya Horticulture Industries AB (publ) ("Oboya") has signed an important and long-term cooperation agreement on environmentally friendly biomaterials with Gaia Biomaterials AB ("Gaia") in Helsingborg, Sweden. The agreement means that Oboya uses Gaias biomaterials for the production and development of environmentally friendly cultivation products for the cultivation industry. Oboya has been actively involved in innovation, environmental and sustainability issues in recent years, and our goal is to encourage environmental and sustainability in the cultivation industry by offering environmentally friendly cultivation products to our customers. Oboya believes that the use of biomaterials will be important for success in the conversion to a fossil-free cultivation industry worldwide. The cooperation agreement means that Oboya uses Gaias biomaterials in its production and that through Gaias expertise we can develop new environmentally friendly cultivation products. Gaias biomaterials are bi

I vårt pressrum kan du läsa de senaste pressmeddelandena, få tillgång till pressmaterial och hitta kontaktinformation.

Besök vårt pressrum